COGENT BIOSCIENCES ANNOUNCES POSITIVE PART 1B DATA FROM SUMMIT TRIAL EVALUATING BEZUCLASTINIB IN PATIENTS WITH NONADVANCED SYSTEMIC MASTOCYTOSIS Registration-enabling SUMMIT Part 2 initiated and actively enrolling at 40 sites globally; RP2D selected at 100 mg...
New collaboration with Kyruus Health to advance care access and outcomes for patients at Nicklaus Children’s Health System BOSTON, MA – Feb. 15, 2024 – Kyruus Health, the leading care access platform, and Nicklaus Children’s Health System, a nationally recognized...
TigerConnect is a 2024 Best in KLAS Award Winner for Clinical Communications TigerConnect ranked as a leading provider in the ambulatory and post-acute care categories SANTA MONICA, Calif., February 7, 2024 — TigerConnect, healthcare’s most trusted clinical...
Bluesight Demonstrates Industry-Leading Performance in Drug Diversion Detection; New Data Highlights 6.6X Advantage Over Competitors Bluesight’s ControlCheck delivers hard outcomes by identifying a diverter every two days ALEXANDRIA, Va., Feb. 7, 2024 — Bluesight, the...
Arvinas Announces First-in-Human Dosing of ARV-102, an Investigational PROTAC® Protein Degrader for Neurodegenerative Disease – ARV-102 is a novel oral PROTAC® protein degrader designed to cross the blood-brain barrier and target leucine-rich repeat kinase 2 (LRRK2) –...
Recent Comments